Recurrence: all 3,523 studies
Page 1 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- A Phase I Clinical Study of YN003 in the Treatment of GliomaRecruitingNCT07929909Phase 1
- Bioavailability and Bioequivalence Study of Ziftomenib in Participants With Relapsed/Refractory AML or MDSNot yet recruitingNCT07929740Phase 1
- BCMA/GPRC5D Dual-Target CAR-T Cell Immunotherapy for Relapsed/Refractory Multiple MyelomaNot yet recruitingNCT07927842Phase 1
- A Study to Assess the Pharmacokinetics and Safety of Revumenib in Participants With Advanced Cancer and Hepatic or Renal ImpairmentNot yet recruitingNCT07923071Phase 1
- Thiotepa + TBI + Fludarabine + Etoposide for Allo-HSCT in Patients With R/R or High-risk Acute LeukemiaEnrolling by invitationNCT07920796Phase 2
- Zilovertamab Vedotin and Lenalidomide (ZiVLen) Therapy for Relapsed/Refractory Peripheral T-Cell LymphomaNot yet recruitingNCT07913594Phase 2
- GN001 for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and B-Cell Acute Lymphoblastic LeukemiaRecruitingNCT07910708Phase 1
- CR-002 in Adult Participants With Locally Advanced or Metastatic Solid TumorsRecruitingNCT07909031Phase 1/2
- Better Care Closer to Home: Enhancing Primary and Community CareNot yet recruitingNCT07905664Not applicable
- Aspirin and PAClitaxel in Head & Neck Squamous Cell CarcinomaNot yet recruitingNCT07901803Phase 2
- A Study of MDSY-1240, a STAT3 Degrader, for the Treatment of Hematologic Malignancies and Advanced Solid TumorsNot yet recruitingNCT07899632Phase 1/2
- Menin Inhibitors in Pediatric Relapsed or Refractory Acute LeukemiaRecruitingNCT07898436
- CLL-1/CD70 Dual-Target CAR-T Cell Therapy for Acute Myeloid LeukemiaNot yet recruitingNCT07897136Phase 1
- CD19 CAR-T Cell Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: A Phase I/II StudyNot yet recruitingNCT07890025Phase 1/2
- Phase I Safety Clinical Trial of Anti-CD19 CAR-T Therapy COL01 for the Treatment of Adults With Relapsed or Refractory B-cell Lymphoid Neoplasms: First-in-human Administration, COLIBRI.Not yet recruitingNCT07883941Phase 1
- Bispecific Antibody-Based Holding/Bridging Therapy Before CAR-T in Aggressive B-Cell LymphomasRecruitingNCT07883135Phase 2
- Mitoxantrone Hydrochloride Liposome Combined With Cladribine And Sotorasib For Relapsed Refractory Acute Myeloid LeukemiaNot yet recruitingNCT07874737Phase 2
- Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use DisorderNot yet recruitingNCT07871877Phase 1/2
- Phase 2a Study to Assess Safety and Efficacy of Two 177Lu-TLX250 Dosing Regimens in Advanced Relapsed or Recurrent ccRCCNot yet recruitingNCT07870746Phase 2
- Study of CDK8 Inhibitor RVU120 in Combination With Everolimus in Children With Recurrent or Progressive Group 3 or 4 MedulloblastomaNot yet recruitingNCT07865130Phase 1
- Inotuzumab as Post-Trasplantation Therapy for Adult High-risk B-cell Precursor Acute Lymphoblastic LeukemiaNot yet recruitingNCT07862946Phase 2
- Management of Non Emergency Adhesive Small Bowel Obstruction:Enrolling by invitationNCT07860177
- Metronomic Temozolomide With Dexbrompheniramine for Recurrent High-Grade Glioma/GlioblastomaNot yet recruitingNCT07859059Phase 1/2
- Incidence and Predictors of Early Clinical Relapse Within Six Months After Thymectomy in Patients With Myasthenia GravisNot yet recruitingNCT07853378
- Immunomonitoring and Predictive Biomarkers After CAR-T Cell Therapy in B-Cell Lymphoma and Multiple MyelomaNot yet recruitingNCT07852377Not applicable
- Roginolisib Plus Obinutuzumab + Venetoclax in R/R CLLNot yet recruitingNCT07847957Phase 1/2
- Phase 1a/1b Clinical Trials to Evaluate the Safety and Preliminary Efficacy of GNTbm-38.Not yet recruitingNCT07842445Phase 1
- CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid LeukemiaNot yet recruitingNCT07841002Phase 1
- Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP TrialNot yet recruitingNCT07840456Phase 2
- Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular CarcinomaRecruitingNCT07840092
- Treatment Selection by 3D Bioprinting Liver Model to Prevent Liver Cancer RecurrenceRecruitingNCT07839767
- Prognosis and Therapeutic Implications in Molecular High-Risk Non-Myoinvasive Endometrial CancerRecruitingNCT07838207
- A Phase 3 Study of Manganese-primed Immunochemotherapy in Patients With Advanced Ovarian CancerRecruitingNCT07822646Phase 3
- Paclitaxel Polymeric Micelles Plus Ivonescimab in Recurrent or Refractory SCLCNot yet recruitingNCT07819591Phase 2
- Radioguided Salvage Pelvic Node Dissection in Oligometastatic Prostate Cancer - SALVAGENot yet recruitingNCT07807293Phase 2
- Prospective One-Year Evaluation of the Safety and Effectiveness of an Investigator-Developed Rectus Abdominis Plication Technique in AbdominoplastyRecruitingNCT07805915Not applicable
- Symptom Trajectory Approaches to ResearchNot yet recruitingNCT07804875
- JSKN033 Versus Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical CancerNot yet recruitingNCT07797153Phase 3
- Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inhibitor or Pirtobrutinib and Previously Treated With a BCL2 InhibitorNot yet recruitingNCT07796373Phase 2
- Pedi-STAR: Surface Target Antibody-drug Conjugate (ADC) Antigen Expression in Relapsed/Refractory Pediatric Solid and CNS TumorsNot yet recruitingNCT07793994Not applicable
- A Clinical Trial Comparing the Efficacy and Safety of Anyouping® and Platinum-based Chemotherapy With or Without Enlituo® in Advanced Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.RecruitingNCT07791745Phase 2/3
- Teclistamab In Waldenstrom's MacroglobulinemiaNot yet recruitingNCT07791498Phase 2
- FH-006 Versus Investigator's Choice of Chemotherapy in Patients With Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma Who Have Failed Prior PD-1/PD-L1 Inhibitor Combined With Platinum-Based Chemotherapy.RecruitingNCT07790380Phase 3
- Mandibular Medial Osteotomy Modifications and Postoperative StabilityRecruitingNCT07788976Not applicable
- A Phase Ib/II Exploratory Clinical Trial of Memory-Enhanced 7×19-THEMIS CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell LymphomaRecruitingNCT07788118Phase 1/2
- A Study of Avatrombopag in Adults With Aplastic Anemia Who Did Not Respond to, Cannot Receive, or Had Return of Disease After Standard TreatmentNot yet recruitingNCT07786922Phase 2/3
- A Phase 3 Study to Compare the Efficacy of ICP-248 in Combination With Orelabrutinib Versus Pirtobrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma (r/r MCL).Not yet recruitingNCT07784101Phase 3
- Venetoclax, Chidamide, and Chiglitazar Sodium (VCC) in Patients With Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT07783100Phase 2
- Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)RecruitingNCT07782164
- RAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCTNot yet recruitingNCT07781891Phase 2
- A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma.RecruitingNCT07779798Phase 1
- Maintenance Individualized Neuromodulation and Depression-detection Via Sensors for Early TreatmentNot yet recruitingNCT07779330Not applicable
- 68Ga-B7-H3 Nanobody ImmunoPET in OsteosarcomaRecruitingNCT07774533Early Phase 1
- Study of Zanzalintinib in Children and Adolescents With Relapsed or Refractory Solid TumorsNot yet recruitingNCT07773454Phase 1
- Validation of the G8 Screening Tool for Prognostic Assessment of Frailty and Early Mortality in Elderly Individuals With Cancer: Prospective Cohort Study in BrazilNot yet recruitingNCT07773285
- A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)RecruitingNCT07771803Early Phase 1
- BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple MyelomaNot yet recruitingNCT07771361Phase 2
- A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic LeukemiaNot yet recruitingNCT07770698Phase 1/2
- Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFUNot yet recruitingNCT07766122Phase 4
- Phase 1 Dose Escalation Study of RXIM002 in Autoimmune CytopeniasNot yet recruitingNCT07765966Phase 1
- CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesNot yet recruitingNCT07763938Phase 1
- Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerNot yet recruitingNCT07763496Phase 2
- Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin LymphomaRecruitingNCT07763210Phase 2
- Middle Meningeal Artery Embolisation in Chronic Subdural HematomaRecruitingNCT07751887Not applicable
- Glofitamab in B-NHL Using Mid-Therapy Intratumoral TranscriptomicsNot yet recruitingNCT07748364Phase 2
- Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)RecruitingNCT07744256Phase 1/2
- Mindfulness-based Relapse Prevention for Peer WorkersRecruitingNCT07741825Not applicable
- SKB264 Plus KL-A167 in MSI-H/dMMR Advanced Gynecological MalignanciesNot yet recruitingNCT07738757Phase 2
- Gene-edited T Regulatory Cells (CRG-150) for the Treatment of Relapsed/Refractory MalignanciesNot yet recruitingNCT07730125Phase 1/2
- A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple MyelomaNot yet recruitingNCT07728188Phase 3
- Low-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple MyelomaRecruitingNCT07725406Phase 1
- ML-016 in Advanced Cancer With Lung and/or Liver InvolvementRecruitingNCT07723482Phase 1/2
- A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)RecruitingNCT07723248Phase 3
- S243249 Monotherapy in Patients With Relapsed or Refractory Acute Leukemia With a KMT2A or NUP98 Translocation or Relapsed or Refractory AML With NPM1c MutationNot yet recruitingNCT07722312Phase 1/2
- In Vivo PICX CAR-T Therapy for R/R Multiple MyelomaRecruitingNCT07715630Phase 1
- TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid TumorsRecruitingNCT07713732Phase 1
- A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure SyndromesRecruitingNCT07712562Phase 1/2
- GLORY: Glofit-GemOx With Liso-Cel For LymphomaRecruitingNCT07711483Phase 2
- A Study of Polatuzumab Vedotin and Glofitamab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Within 12 Months After R-CHOPNot yet recruitingNCT07702851Phase 2
- LASER VERSUS CRYSTALLIZED PHENOL IN PILONIDAL SINUS DISEASERecruitingNCT07701772Not applicable
- Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute LeukemiaNot yet recruitingNCT07696481Early Phase 1
- Real-World Study of Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin LymphomaNot yet recruitingNCT07695896
- Study of YKST02 in Adults With Relapsed or Refractory Multiple MyelomaNot yet recruitingNCT07695740Phase 2
- CAR-T Cell Therapy for ALLRecruitingNCT07695012Early Phase 1
- Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's DiseaseRecruitingNCT07694674
- CAR-T in Relapsed/Refractory Multiple MyelomaRecruitingNCT07689058Phase 2
- Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell CarcinomaNot yet recruitingNCT07686744Phase 1
- Sacituzumab Tirumotecan Plus Immunotherapy for Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT07686588Phase 2
- Research on Early Recurrence of Locally Advanced Gastric Cancer Based on CT Radiomics PredictionEnrolling by invitationNCT07683195
- Study to Evaluate the Efficacy of Zanzalintinib in the Treatment of Relapsed or Metastatic Adenoid Cystic Carcinomas of the Head and NeckNot yet recruitingNCT07682675Phase 2
- A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple MyelomaRecruitingNCT07681596Phase 1/2
- Tisotumab Vedotin in Squamous Cell Carcinoma of the VulvaNot yet recruitingNCT07672782Phase 2
- GoFast CAR T-Cell Therapy for Recurrent Refractory B-Cell LymphomaNot yet recruitingNCT07670260Early Phase 1
- Glofitamab Combined With Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell LymphomaNot yet recruitingNCT07669194
- Anti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT07668557Phase 1
- A Phase II Trial for MOR Antagonism With Axelopran to Enhance Immunotherapy in Head and Neck CancerNot yet recruitingNCT07662720Phase 1/2
- Prevention of Postpartum Smoking Relapse and Related Health Consequences by Breastfeeding PromotionRecruitingNCT07661550Not applicable
- CCR2 PET Imaging Head and Neck Squamous Cell CarcinomaRecruitingNCT07659678Phase 2
- Non-Thermal Plasma to Reduce Recurrence in Chronic Subdural HematomaRecruitingNCT07656818Not applicable
- TTE Study of QL1706 in Recurrent/Metastatic Cervical CancerNot yet recruitingNCT07652983